BIOANCIENT: Cohort of Centenarians in Navarra (1926-1927)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age100+
SponsorFundacion Miguel Servet

About this trial

Demographic aging is a growing global challenge, driven by increasing life expectancy and declining birth rates, with projections indicating that more than 30% of the European population will be over 65 years old by 2100. Centenarians represent a unique biological model of extreme longevity, often exhibiting delayed onset of age-related diseases and preserved functional capacity.

This study aims to establish an intergenerational cohort of centenarians in Navarra (Spain) to investigate the biological, clinical, environmental, and lifestyle factors associated with extreme longevity. By integrating multidimensional data-including clinical assessments, functional and cognitive measures, and biological markers-this study seeks to improve understanding of aging mechanisms and identify potential determinants of healthy aging.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Individuals aged ≥100 years

Residents of Navarre, Spain

Disqualifiers

Clinical decompensation within the last month, including hemodynamic instability, acute illness, or hospitalization;

End-of-life condition, defined as a clinical state of irreversible deterioration with a life expectancy of days to weeks, as determined by a physician.

Trial population

The study population consists of very old adults aged 100 years and older residing in Navarre, Spain. Participants will be community-dwelling or institutionalized individuals who meet the inclusion criteria and are able to undergo a comprehensive geriatric assessment. The study aims to include a representative sample of the centenarian population in the region.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

333 Participants
are grouped into 1 trial group
Group A: Centenarians resident in Navarre - Spain

Trial outcomes

Primary outcomes

1

Integrated biological aging profile based on clinical and multi-omics biomarkers.

Clinical, funtional and molecular characterization of centenarian individuals using multi-omics biomarkers

Time frame
Baseline and 1-year follow-up

Secondary outcomes

1

Cognitive Function assessed with Mini Mental State Examination (MMSE)

Cognitive Function assessed with Mini-Mental State Examination (MMSE) is a 30-point tool designed to assess global cognitive function and screen for cognitive impairment, particularly in older adults. It evaluates several core areas of cognitive functioning, with higher scores indicating better cognitive performance, i.e. 30 (best) and 0 (worst). The 11 tasks in the MMSE are generally categorized into the following areas of cognitive functioning: Orientation (10 points), Registration (3 points), Attention and Calculation (5 points); Recall (3 points): .Language and Praxis (9 points).

Time frame
Baseline and 1-year follow-up
2

Functional status measured with Barthel Index

Barthel Index of independence during activities of daily living (ADLs) ranges from 0 (severe functional dependence) to 100 (functional independence).

Time frame
Baseline and 1-year follow-up
3

Physical function assessed by Short Physical Performance Battery (SPPB)

Physical Function: Assessed using the Short Physical Performance Battery (SPPB), which combines balance, gait velocity, and leg strength as a single score on a 0 (worst) to 12 (best scale).

Time frame
Baseline and 1-year follow-up
4

Frailty assessed by Fried Frailty Phenotype

The Fried Frailty Phenotype is a widely used clinical tool that defines frailty as a distinct syndrome in older adults, based on five key physical markers: unintentional weight loss, self-reported exhaustion, low physical activity, weak grip strength, and slow walking speed. It identifies individuals as frail if they meet 3 or more criteria, and pre-frail if they meet 1-2. Namely, 0 (best) and 5 (worst).

Time frame
Baseline and 1-year follow-up

Other outcomes

1

Baseline Demographics and Socio-Environmental Profile

Collection of baseline characteristics prior to the appointment, structured into 4 areas: Core Demographics: Date of birth, age (years), biological sex, gender identity, and marital status. Socio-Educational \& Occupational History: Educational level, age of completion, lifelong occupation, retirement year, and family longevity (parents/siblings age of death). Geographic \& Living Environment: Birthplace, lifelong/current residence, housing type (single/multi-family/nursing home), and environment (rural/urban). Social Support \& Neighborhood Accessibility: Household composition (alone, partner, relatives, external caregivers), family structure (children, grandchildren), primary caregiver, and external networks. Walking accessibility to health, basic needs, social services, and transport is evaluated (Yes/No). Data reported as descriptive baseline statistics: continuous variables as means/medians, and categorical items as counts/percentages.

Time frame
Baseline
2

Lifestyle Factors

Lifestyle factors assessed through structured questionnaires, including dietary habits (e.g., frequency of food group consumption), physical activity (e.g., frequency, duration, and intensity of activity), and social engagement (e.g., participation in social activities and social support). Higher levels of physical activity and social engagement and healthier dietary patterns indicate more favorable lifestyle profiles.

Time frame
Baseline (single assessment)
3

Other Geriatric Syndromes and Health Dimensions

A multidimensional clinical assessment of secondary geriatric syndromes evaluating seven core domains: 1) Sleep Quality \& Restfulness (subjective quality \[Good/Fair/Poor\] and feeling rested \[Yes/No\]); 2) Insomnia Profile (presence, onset latency, and frequent awakenings \[Yes/No\]); 3) Hearing Status (subjective impairment, hearing aid use, and persistent deficit \[Yes/No\]); 4) Objective Hearing (Whisper Test) (number of words correctly repeated out of 4 at 0.6 meters for each ear \[Score 0-4\]); 5) Vision \& Ocular Symptoms (near/distance impairment with glasses, ocular pain and discomfort \[Yes/No\]); 6) Pain Dimension (current and lifetime presence, limiting capacity, quality of life impact \[Yes/No\], and location); and 7) Dermatological Status (skin alterations and delayed wound healing \[Yes/No\]).

Time frame
Baseline and 1-year follow-up

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fundacion Miguel Servet

Lead sponsor

Gobierno de Navarra

Collaborator